Correlation Between Centessa Pharmaceuticals and Valens

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Valens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Valens into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Valens, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Valens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Valens. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Valens.

Diversification Opportunities for Centessa Pharmaceuticals and Valens

0.03

Correlation Coefficient

Centessa Pharmaceuticals  Valens

Significant diversification

The 3 months correlation between Centessa and Valens is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Valens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valens and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Valens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valens has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Valens go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Valens

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.6 times more return on investment than Valens. However, Centessa Pharmaceuticals PLC is 1.68 times less risky than Valens. It trades about 0.03 of its potential returns per unit of risk. Valens is currently generating about -0.02 per unit of risk. If you would invest  1,704  in Centessa Pharmaceuticals PLC on September 23, 2024 and sell it today you would earn a total of  12.00  from holding Centessa Pharmaceuticals PLC or generate 0.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  Valens

Centessa Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Valens

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Valens has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Centessa Pharmaceuticals and Valens

The main advantage of trading using opposite Centessa Pharmaceuticals and Valens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Valens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valens will offset losses from the drop in Valens' long position.

The idea behind Centessa Pharmaceuticals PLC and Valens pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.